Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

Multidisciplinary Panel Discussion: New Treatment Options for Surgic…

David Carbone

B. Stiles

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…

2024 ASCO® Annual Meeting Insights Hub

L. Raez

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics

Springer Healthcare IME

S. Peters

UChicago Medicine Best of ASCO® 2024: NSCLC

UChicago Medicine Annual Practice Updates in Hematology and Oncology

R. Thawani

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

An Update on Lung Cancer Targeted Therapies: The Evolution of Person…

University of Miami Sylvester Comprehensive Cancer Center

E. Rodriguez

Management of mNSCLC Without Actionable Mutations

Integrity CE

M. Baumgart, S. Liu

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in …

2024 ASCO® Annual Meeting Insights Hub

T. Mok

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

How the Experts Treat: Early Stage NSCLC With Curative Intent

Integrity CE

S. Liu

Management of Stage IV NSCLC With Actionable Mutations

Integrity CE

G. Dy

ADCs and Bispecific Inhibitors in NSCLC

Chul Kim

ADC in Combination With Immunotherapy for NSCLC

MI&T Congressi

S. Liu

Options for ALK+ NSCLC

MI&T Congressi

J. Lin

The Era of Precision Oncology

Springer Healthcare IME

J. Schneider

Biomarker Testing in NSCLC

Martin Dietrich